Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,104 recruiting studies in this area right now.
By phase
- Not applicable4,205
- Phase 2592
- Phase 1413
- Phase 3328
- Phase 4254
- Phase 1/Phase 2245
- Phase 2/Phase 367
Top conditions
- Ovarian Cancer338
- Cervical Cancer225
- Endometrial Cancer210
- Bladder Cancer188
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy129
- Chronic Kidney Diseases123
- Breast Cancer112
- Chronic Kidney Disease108
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS45
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong34
Where studies are running
- California351
- Alabama153
- Texas119
- Massachusetts117
- New York116
- Arizona106
- Florida103
- Maryland87
- Colorado84
- Illinois79
Recruiting studies6,104 total
- NCT06150742Recruiting
Nafamostat for dialysis patients who can't use heparin
This trial tests a new medicine called nafamostat to prevent blood clots during continuous dialysis (CRRT), for people who are at high risk of bleeding or can't take heparin.
Los Angeles, CaliforniaAges 18–80 - NCT06142760Recruiting
MRI-guided chemoradiation for cervical cancer
This trial uses MRI scans during chemoradiation to improve treatment accuracy for cervical cancer. It may help patients who need standard chemoradiation plus brachytherapy.
HeidelbergAges 18 years+ - NCT06147388Recruiting
Can cervical precancer heal on its own?
This study watches to see if early precancerous cells (CIN 2 or 3) on the cervix can go away without treatment, especially in women under 40. It helps doctors understand who might avoid surgery.
PragueAges 18–40 - NCT06138067Recruiting
Navigator program to help cancer patients join clinical trials
This study tests if a patient navigator can help more people with prostate or kidney cancer enroll in clinical trials. You may be assigned to work with a navigator who helps find a trial that fits your needs.
Baltimore, MarylandAges 18 years+ - NCT06148532Enrolling by invitation
Reducing illness from maternal sepsis study
This study looks at medical records of people who gave birth and were later readmitted to the hospital for postpartum care. It aims to find better ways to prevent and treat sepsis, a serious infection, in mothers.
New York, New YorkAges 18 years+ - NCT06145139Enrolling by invitation
Liquid biopsy for kidney cancer: tracking tumor DNA after surgery
This study looks at whether a simple blood test can detect tiny bits of kidney cancer DNA after surgery. If successful, it could help doctors spot a return of cancer earlier than scans alone.
Aarhus NAges 18 years+ - NCT06147414Recruiting
Blood test for genetic disorders in pregnancy
This study tests a safer blood test to check for certain genetic disorders during pregnancy, instead of an invasive procedure like amniocentesis. It's for pregnant women who are at risk of passing on a known genetic condition.
ParisAges 18 years+ - NCT06130371Recruiting
Stress, Inflammation & Brain in Depression vs. Severe PMS
This study looks at how stress and inflammation affect the brain in women with major depression compared to women with severe PMS (PMDD). It could help find better ways to understand and treat these mood disorders.
Tübingen, Baden-WurttembergAges 18–40 - NCT06145724Recruiting
Reducing maternal sepsis complications in New York City hospitals
This study looks at hospital records to find ways to reduce serious infections (sepsis) in mothers after childbirth. It aims to improve care and save lives.
New York, New YorkAges Any age - NCT06147960Recruiting
Cancer cell proteins and cervical cancer return risk
This trial looks at whether certain proteins that stop cell death (called inhibitor of apoptosis proteins) in cervical cancer tissue can help predict if the cancer will come back after treatment. It studies patients who had chemoradiation for advanced cervical cancer.
Nîmes, GardAges 18 years+ - NCT06142396RecruitingEarly Phase 1
Dara-CyBorD for New Multiple Myeloma with Kidney Failure
This pilot study tests a combination of four drugs (daratumumab, cyclophosphamide, bortezomib, and dexamethasone, known as Dara-CyBorD) in people newly diagnosed with multiple myeloma who also have kidney problems. The goal is to see if this treatment is safe and effective for this specific group.
Augusta, GeorgiaAges 18–80 - NCT06141265RecruitingPhase 2
Niraparib maintenance after chemo and Avastin for advanced ovarian cancer
This trial tests whether the PARP inhibitor niraparib can help keep advanced ovarian cancer from coming back. You may qualify if you have a BRCA mutation or HRD-positive tumor and finished first-line chemotherapy with bevacizumab (Avastin) with good response.
Beijing, Beijing MunicipalityAges 18–75 - NCT06138561Recruiting
Bladder cancer treatment study for older adults
This study looks at how well different treatments work for older adults with bladder cancer that has spread and who cannot take cisplatin. It also checks if geriatric assessments help guide care.
Boston, MassachusettsAges 65 years+ - NCT06153303Recruiting
Online therapy for endometriosis and chronic pain
This trial tests if an internet-based program based on acceptance and commitment therapy (ACT) can help people with endometriosis and chronic pain. It aims to improve daily functioning and quality of life.
Lund, Skåne CountyAges 18–65 - NCT06126276RecruitingPhase 2
Testing neratinib with or without palbociclib for HER2+ solid tumors
This trial tests two targeted drugs—neratinib alone or with palbociclib—for people with HER2-positive solid tumors (other than breast cancer) that have returned or not gone away. The goal is to see if blocking HER2 and CDK4/6 can shrink or slow the tumor.
Birmingham, AlabamaAges 18 years+ - NCT06110130RecruitingPhase 4
Empagliflozin for kidney health in African American veterans
This study is testing whether the drug empagliflozin (Jardiance) can help protect the kidneys of African American veterans who already have some kidney damage but do not have diabetes. The goal is to see if the drug can reduce damage at the cellular level.
Washington D.C., District of ColumbiaAges 19–90 - NCT06113237Recruiting
Epidiolex pregnancy safety study
This study tracks the safety of Epidiolex (a prescription CBD medicine) when taken during pregnancy. It helps doctors understand how the medicine affects pregnancy and the baby.
Morgantown, West VirginiaAges Any age - NCT06121297RecruitingPhase 1/Phase 2
CABA-201 treatment for systemic lupus erythematosus
This study tests a new treatment called CABA-201 for people with active systemic lupus erythematosus (SLE). The treatment aims to reduce disease activity and may help those who haven't responded well to other treatments.
Orange, CaliforniaAges 12–65 - NCT06126380Enrolling by invitationPhase 2
Long-term safety of tegoprubart in kidney transplant patients
This is a long-term follow-up study for people who have already completed a study of the drug tegoprubart after a kidney transplant. It checks how safe and effective the drug is over a longer period.
Los Angeles, CaliforniaAges 18–100 - NCT06127199Recruiting
Birth control ring study for women
This study tests a new vaginal ring for birth control. If you join, you will use the ring as your only method of preventing pregnancy for about 13 months.
Phoenix, ArizonaAges 18–40 - NCT06128551RecruitingPhase 1/Phase 2
Testing two targeted drugs for KRAS G12C advanced cancer
This study tests two oral medicines (elironrasib and daraxonrasib) given alone or together to see if they can shrink tumors or slow down cancer growth in people with advanced solid tumors that have a KRAS G12C mutation. It is for people who have already tried other treatments.
Duarte, CaliforniaAges 18 years+ - NCT06122207Recruiting
Probiotic for women with fertility issues and IVF
This study tests whether a probiotic (a pill with beneficial bacteria) can help improve the health of the female genital tract for people with fertility problems who are undergoing IVF. It aims to see if this can improve chances of pregnancy.
LisbonAges 18–45 - NCT03160274Recruiting
Genetic testing for certain adrenal and nerve tumors
This study looks at genetic (DNA) changes in people with pheochromocytoma or paraganglioma and related conditions. It may help clarify why these conditions happen and how they run in families.
San Antonio, TexasAges Any age - NCT04586959Recruiting
Uterine movement study during minimally invasive cancer surgery
This study looks at how moving the uterus during minimally invasive surgery may affect women with early-stage endometrial cancer. It may help doctors choose the safest, most effective surgical approach.
Cleveland, OhioAges 18–90
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,104 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,983 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.